Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Q1 Scientific
Q1 Scientific
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
Tim Slomp joins executive board of Uhlmann
Slomp will succeed Peter Wagner as Managing Director Technology & Development in January 2018
Change of CEO at BASF
Lanxess announces change of leadership at Board of Management
Matthias Zachert joins as Chief Executive and Chairman from Merck KGaA
Why the strategic benefits of outsourcing formulation development matter
The formulation development outsourcing market continues to grow at pace as pharmaceutical companies experience first-hand the strategic advantages that a solid partnership has...
Aurorium launches Haelium Pharmaceutical Solutions
The creation will expand Aurorium's global capabilities in pharmaceutical ingredient production
Upcoming event
CPhI South East Asia 2024
10-12 July 2024 | Exhibition and Conference | Bangkok, Thailand
See all
Related Content
Manufacturing
Cambrex acquires leading EU stability storage company Q1 Scientific
Stability storage and testing is a critical component of drug development and commercialisation of new therapies
Manufacturing
Top 5 tips for better stability monitoring
Based on our experience providing stability storage this article provides our top 5 tips for better stability monitoring
Manufacturing
Q1 Scientific shares results of Thermal Cycling/Freeze Thaw Study
Thermal Cycling gives an indication as to how a product will react to adverse conditions, usually encountered during transportation
Subscribe now